Biotech Values

[DewDiligence]

ENTA’s General Counsel exercised-and-held $300K of stock on 9/27/19:

https://www.sec.gov/Archives/edgar/data/1177648/000117764819000034/xslF345X03/edgar.xml

The exercised options did not expire until 2026.

The above transaction is in addition to: the $270K exercise-and-hold in Jun 2019 (#msg-149617660); the $250K exercise-and-hold in Mar 2019 (#msg-147373277); and the $150K exercise-and-hold in Jan 2019 (#msg-146329304).

That sums to $970M of stock in four exercise-and-hold transactions by the General Counsel.